Publications by authors named "Ted Burns"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

2,397

Total Likes

587

Extended Reach

1,199,066

Social Features

264
S
Shared burden of ultra-rare genetic variants across a spectrum of motor neuron diseases.
Gang Wu, Wenan Chen, Joanne Wuu, Angita Jain, Jason Myers, Ted M Burns

Transl Neurodegener· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring treatment adverse event burden in myasthenia gravis: Single-center prospective evaluation utilizing the Adverse Event Unit (AEU).
Michael K Hehir, Mark Conaway, Avery B St Sauveur, Kendall Feb, Noah A Kolb, Ted M Burns

Muscle Nerve· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Adverse Event Unit (AEU): A novel metric to measure the burden of treatment adverse events.
Michael K Hehir, Mark Conaway, Eric M Clark, Denise B Aronzon, Noah Kolb, Ted M Burns

PLoS One· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.
Richard J Nowak, Christopher S Coffey, Jonathan M Goldstein, Mazen M Dimachkie, Michael Benatar, Ted M Burns

Neurology· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial.
Richard J Barohn, Byron Gajewski, Mamatha Pasnoor, Alexandra Brown, Laura L Herbelin, Ted Burns

JAMA Neurol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric longitudinal evaluation of the Chronic Acquired Polyneuropathy Patient-Reported Index (CAPPRI) in patients with chronic inflammatory demyelinating polyneuropathy.
Reza Sadjadi, Stojan Peric, Kelly Gwathmey, Ivo Bozovic, Palibrk Aleksa, Ted Burns

Muscle Nerve· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis.
Katerina Placek, Michael Benatar, Joanne Wuu, Evadnie Rampersaud, Laura Hennessy, Ted M Burns

EMBO Mol Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A crisis in US drug pricing: Consequences for patients with neuromuscular diseases, physicians and society, part 1.
Ted M Burns, Jason L Crowell, A Gordon Smith

Muscle Nerve· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A crisis in US drug pricing: Consequences for patients with neuromuscular diseases, physicians, and society, part 2.
Ted M Burns, Jason L Crowell, A Gordon Smith

Muscle Nerve· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rising Drug Costs for Neurologic Diseases.
Jason L Crowell, Ted M Burns

Continuum (Minneap Minn)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS.
Michael Benatar, Lanyu Zhang, Lily Wang, Volkan Granit, Jeffrey Statland, Ted M Burns

Neurology· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovations in on-demand audio education: Beyond trending.
Jeffrey Ratliff, Jason Crowell, Stacey L Clardy, Ted Burns

Neurology· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment.
Gary Cutter, Haichang Xin, Inmaculada Aban, Ted M Burns, Phillip H Allman

Muscle Nerve· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Acquired Polyneuropathy Patient Reported Index (CAPPRI) in chronic inflammatory demyelinating polyradiculoneuropathy.
Bogdan Bjelica, Stojan Peric, Kelly Gwathmey, Reza Sadjadi, Ivo Bozovic, Ted M Burns

J Peripher Nerv Syst· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the psychometric properties of the inclusion body myositis functional rating scale with rasch analysis.
Gita Ramdharry, Jasper Morrow, Stacie Hudgens, Iwona Skorupinska, Kelly Gwathmey, Ted M Burns

Muscle Nerve· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.
Srikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, Hiroyuki Murai, Richard J Barohn, Ted M Burns

Muscle Nerve· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis.
James F Howard, Vera Bril, Ted M Burns, Renato Mantegazza, Malgorzata Bilinska

Neurology· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis.
Katherine M Clifford, Lisa D Hobson-Webb, Michael Benatar, Ted M Burns, Carolina Barnett

Muscle Nerve· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcome assessments: The "Rasch-Ionale" for improved accuracy.
Pushpa Narayanaswami, Ted M Burns

Muscle Nerve· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating and managing fatigue for our patients: Are we measuring up?
Ted M Burns

Muscle Nerve· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical research in chemotherapy-induced peripheral neuropathy: How, what, and when.
Noah Kolb, Ted Burns

Neurology· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI.
Kelly G Gwathmey, Reza Sadjadi, William B Horton, Mark R Conaway, Carolina Barnett-Tapia, Ted M Burns

Neurology· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
James F Howard, Kimiaki Utsugisawa, Michael Benatar, Hiroyuki Murai, Richard J Barohn, Ted M Burns

Lancet Neurol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review.
Michael K Hehir, Lisa D Hobson-Webb, Michael Benatar, Carolina Barnett, Nicholas J Silvestri, Ted M Burns

Neurology· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis